Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1985 Feb;38(2):117–127. doi: 10.1136/jcp.38.2.117

Biochemical enzyme analysis in acute leukaemia.

H G Drexler, G Gaedicke, J Minowada
PMCID: PMC499089  PMID: 2981904

Abstract

This report summarises the current knowledge regarding the clinical utility of biochemical enzyme markers for both diagnostic and therapeutic purposes in acute leukaemia. The enzymes studied most extensively in this field are terminal deoxynucleotidyl transferase, adenosine deaminase, 5'-nucleotidase, purine nucleoside phosphorylase, and acid phosphatase, esterase, hexosaminidase isoenzymes. For each enzyme, the quantitative and qualitative characteristics in various immunologically defined subclasses of acute leukaemia are described. The quantitative evaluation of enzyme activities represents an adjunctive classification technique which should be incorporated into the multivariate analysis, the "multiple marker analysis." By qualitative characterisation pronounced heterogeneity of leukaemia subsets is uncovered. The application of 2'-deoxycoformycin, a specific inhibitor of adenosine deaminase, and the potential usefulness of two other enzymes as targets for treatment with selective agents is discussed. The concept that gene products expressed at certain developmental stages of normal cells can similarly be detected in leukaemic cells (which therefore seem to be "frozen" or "arrested" at this particular maturation/differentiation stage) is supported by the results obtained in enzyme studies. Besides their practical clinical importance for classification and treatment of acute leukaemias, biochemical enzyme markers constitute a valuable research tool to disclose biological properties of leukaemic cells.

Full text

PDF
117

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ben-Bassat I., Simoni F., Holtzman F., Ramot B. Adenosine deaminase activity of normal lymphocytes and leukemic cells. Isr J Med Sci. 1979 Nov;15(11):925–927. [PubMed] [Google Scholar]
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  3. Bertazzoni U., Brusamolino E., Isernia P., Scovassi A. I., Torsello S., Lazzarino M., Bernasconi C. Prognostic significance of terminal transferase and adenosine deaminase in acute and chronic myeloid leukemia. Blood. 1982 Sep;60(3):685–692. [PubMed] [Google Scholar]
  4. Besley G. T., Broadhead D. M., Bain A. D., Dewar A. E., Eden O. Enzyme markers in acute lymphoblastic leukaemia. Lancet. 1978 Dec 16;2(8103):1311–1311. doi: 10.1016/s0140-6736(78)92074-3. [DOI] [PubMed] [Google Scholar]
  5. Blatt J., Reaman G. H., Levin N., Poplack D. G. Purine nucleoside phosphorylase activity in acute lymphoblastic leukemia. Blood. 1980 Sep;56(3):380–382. [PubMed] [Google Scholar]
  6. Blatt J., Reaman G., Poplack D. G. Current concepts. Biochemical markers in lymphoid malignancy. N Engl J Med. 1980 Oct 16;303(16):918–922. doi: 10.1056/NEJM198010163031606. [DOI] [PubMed] [Google Scholar]
  7. Bloomfield C. D., Gajl-Peczalska K. J. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma. Curr Top Hematol. 1980;3:175–240. [PubMed] [Google Scholar]
  8. Bollum F. J. Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood. 1979 Dec;54(6):1203–1215. [PubMed] [Google Scholar]
  9. Bradstock K. F., Hoffbrand A. V., Ganeshaguru K., Llewellin P., Patterson K., Wonke B., Prentice A. G., Bennett M., Pizzolo G., Bollum F. J. Terminal deoxynucleotidyl transferase expression in acute non-lymphoid leukaemia: an analysis by immunofluorescence. Br J Haematol. 1981 Jan;47(1):133–143. doi: 10.1111/j.1365-2141.1981.tb02767.x. [DOI] [PubMed] [Google Scholar]
  10. Bradstock K. F., Papageorgiou E. S., Janossy G., Hoffbrand A. V., Willoughby M. L., Roberts P. D., Bollum F. J. Detection of leukaemic lymphoblasts in CSF by immunofluorescence for terminal transferase. Lancet. 1980 May 24;1(8178):1144–1144. doi: 10.1016/s0140-6736(80)91599-8. [DOI] [PubMed] [Google Scholar]
  11. Broadhead D. M., Besley G. T., Moss S. E., Bain A. D., Eden O. B., Sainsbury C. P. Recognition of abnormal lysosomal enzyme patterns in childhood leukaemia by isoelectric focusing, with special reference to some properties of abnormally expressed components. Leuk Res. 1981;5(1):29–40. doi: 10.1016/0145-2126(81)90094-1. [DOI] [PubMed] [Google Scholar]
  12. Brusamolino E., Bertazzoni U., Isernia P., Ginelli E., Scovassi A. I., Zurlo M. G., Plevani P., Sacchi N., Bernasconi C. Clinical relevance of terminal transferase and adenosine deaminase in leukemia. Adv Exp Med Biol. 1982;145:279–303. doi: 10.1007/978-1-4684-8929-3_24. [DOI] [PubMed] [Google Scholar]
  13. Catovsky D., Pittman S., O'Brien M., Cherchi M., Costello C., Foa R., Pearce E., Hoffbrand A. V., Janossy G., Ganeshaguru K. Multiparameter studies in lymphoid leukemias. Am J Clin Pathol. 1979 Oct;72(4 Suppl):736–745. [PubMed] [Google Scholar]
  14. Chechik B. E., Rao J., Greaves M. F., Hoffbrand A. V. Human thymus/leukaemia-associated antigen (a low-molecular weight form of adenosine deaminase) and the phenotype of leukaemic cells. Leuk Res. 1980;4(4):343–349. doi: 10.1016/0145-2126(80)90089-2. [DOI] [PubMed] [Google Scholar]
  15. Coleman M. S., Greenwood M. F., Hutton J. J., Holland P., Lampkin B., Krill C., Kastelic J. E. Adenosine deaminase, terminal deoxynucleotidyl transferase (TdT), and cell surface markers in childhood acute leukemia. Blood. 1978 Dec;52(6):1125–1131. [PubMed] [Google Scholar]
  16. Conklyn M. J., Silber R. Properties of lymphocyte 5'nucleotidase in normal subjects and patients with chronic lymphocytic leukemia. Leuk Res. 1982;6(2):203–210. doi: 10.1016/0145-2126(82)90026-1. [DOI] [PubMed] [Google Scholar]
  17. Demeocq F., Viallard J. L., Boumsell L., Richard Y., Chassagne J., Plagne R., Lemerle J., Bernard A. The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies. Leuk Res. 1982;6(2):211–220. doi: 10.1016/0145-2126(82)90027-3. [DOI] [PubMed] [Google Scholar]
  18. Dewji N., Rapson N., Greaves M., Ellis R. Isoenzyme profiles of lysosomal hydrolases in leukaemic cells. Leuk Res. 1981;5(1):19–27. doi: 10.1016/0145-2126(81)90093-x. [DOI] [PubMed] [Google Scholar]
  19. Drexler H. G., Gaedicke G. Analysis of isoenzyme patterns of acid phosphatase in acute leukemias. Blut. 1983 Aug;47(2):105–113. doi: 10.1007/BF02482644. [DOI] [PubMed] [Google Scholar]
  20. Drexler H. G., Gaedicke G. Isoenzyme studies in human leukemia -- II. Carboxylic esterase (E.C. 3.1.1.1.). Leuk Res. 1983;7(5):599–609. doi: 10.1016/0145-2126(83)90131-5. [DOI] [PubMed] [Google Scholar]
  21. Drexler H. G., Gaedicke G. Isoenzyme studies in human leukemia -- III. beta-Hexosaminidase (E.C. 3.2.1.30). Leuk Res. 1983;7(5):611–619. doi: 10.1016/0145-2126(83)90132-7. [DOI] [PubMed] [Google Scholar]
  22. Dunn N. L., Maurer H. M. Enzyme alterations in leukemic cells. Am J Hematol. 1982 Dec;13(4):343–351. doi: 10.1002/ajh.2830130411. [DOI] [PubMed] [Google Scholar]
  23. Edwards N. L., Magilavy D. B., Cassidy J. T., Fox I. H. Lymphocyte ecto-5'-nucleotidase deficiency in agammaglobulinemia. Science. 1978 Aug 18;201(4356):628–630. doi: 10.1126/science.27864. [DOI] [PubMed] [Google Scholar]
  24. Ellis R. B., Rapson N. T., Patrick A. D., Greaves M. F. Expression of hexosaminidase isoenzymes in childhood leukemia. N Engl J Med. 1978 Mar 2;298(9):476–480. doi: 10.1056/NEJM197803022980902. [DOI] [PubMed] [Google Scholar]
  25. Foon K. A., Schroff R. W., Gale R. P. Surface markers on leukemia and lymphoma cells: recent advances. Blood. 1982 Jul;60(1):1–19. [PubMed] [Google Scholar]
  26. Gaedicke G., Arndt R., Kabisch H., Landbeck G. Isoenzyme studies in human leukemia. I. Acid phosphatase. Leuk Res. 1979;3(6):417–423. doi: 10.1016/0145-2126(79)90038-9. [DOI] [PubMed] [Google Scholar]
  27. Gaedicke G., Drexler H. G. Leukemic cell differentiation in childhood leukemias. Analysis by enzyme markers. Eur J Pediatr. 1984 Aug;142(3):157–164. doi: 10.1007/BF00442441. [DOI] [PubMed] [Google Scholar]
  28. Gan T. E., Hallam L., Van der Weyden M. B. Purine and pyrimidine activities in acute and chronic lymphocytic leukaemia: relation to cellular proliferative status. Leuk Res. 1982;6(6):839–844. doi: 10.1016/0145-2126(82)90068-6. [DOI] [PubMed] [Google Scholar]
  29. Ganeshaguru K., Lee N., Llewellin P., Prentice H. G., Hoffbrand A. V., Catovsky D., Habeshaw J. A., Robinson J., Greaves M. F. Adenosine deaminase concentrations in leukaemia and lymphoma: relation to cell phenotypes. Leuk Res. 1981;5(3):215–222. doi: 10.1016/0145-2126(81)90106-5. [DOI] [PubMed] [Google Scholar]
  30. Giblett E. R., Ammann A. J., Wara D. W., Sandman R., Diamond L. K. Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity. Lancet. 1975 May 3;1(7914):1010–1013. doi: 10.1016/s0140-6736(75)91950-9. [DOI] [PubMed] [Google Scholar]
  31. Giblett E. R., Anderson J. E., Cohen F., Pollara B., Meuwissen H. J. Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. Lancet. 1972 Nov 18;2(7786):1067–1069. doi: 10.1016/s0140-6736(72)92345-8. [DOI] [PubMed] [Google Scholar]
  32. Gordon D. S., Hutton J. J., Smalley R. V., Meyer L. M., Volger W. R. Terminal deoxynucleotidyl transferase (TdT), cytochemistry, and membrane receptors in adult acute leukemia. Blood. 1978 Dec;52(6):1079–1088. [PubMed] [Google Scholar]
  33. Greaves M. F. "Target" cells, cellular phenotypes, and lineage fidelity in human leukaemia. J Cell Physiol Suppl. 1982;1:113–125. doi: 10.1002/jcp.1041130418. [DOI] [PubMed] [Google Scholar]
  34. Greaves M. F., Hariri G., Newman R. A., Sutherland D. R., Ritter M. A., Ritz J. Selective expression of the common acute lymphoblastic leukemia (gp 100) antigen on immature lymphoid cells and their malignant counterparts. Blood. 1983 Apr;61(4):628–639. [PubMed] [Google Scholar]
  35. Greaves M., Janossy G. Patterns of gene expression and the cellular origins of human leukaemias. Biochim Biophys Acta. 1978 Oct 27;516(2):193–230. doi: 10.1016/0304-419x(78)90008-2. [DOI] [PubMed] [Google Scholar]
  36. Greaves M., Verbi W., Vogler L., Cooper M., Ellis R., Ganeshaguru K., Hoffbrand V., Janossy G., Bollum F. J. Antigenic and enzymatic phenotypes of the pre-B subclass of acute lymphoblastic leukaemia. Leuk Res. 1979;3(6):353–362. doi: 10.1016/0145-2126(79)90032-8. [DOI] [PubMed] [Google Scholar]
  37. Greenwood M. F., Coleman M. S., Hutton J. J., Lampkin B., Krill C., Bolium F. J., Holland P. Terminal deoxynucleotidyltransferase distribution in neoplastic and hematopoietic cells. J Clin Invest. 1977 May;59(5):889–899. doi: 10.1172/JCI108711. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Gutensohn W., Thiel E. The significance of ecto-5'-nucleotidase in lymphoid blast crisis of chronic myeloid leukemia. Blood. 1982 Aug;60(2):536–537. [PubMed] [Google Scholar]
  39. Hoffbrand A. V., Ganeshaguru K., Janossy G., Greaves M. F., Catovsky D., Woodruff R. K. Terminal deoxynucleotidyl-transferase levels and membrane phenotypes in diagnosis of acute leukaemia. Lancet. 1977 Sep 10;2(8037):520–523. doi: 10.1016/s0140-6736(77)90662-6. [DOI] [PubMed] [Google Scholar]
  40. Hoffbrand A. V., Ganeshaguru K., Llewelin P., Janossy G. Biochemical markers in leukaemia and lymphoma. Recent Results Cancer Res. 1979;69:25–39. doi: 10.1007/978-3-642-81371-9_4. [DOI] [PubMed] [Google Scholar]
  41. Hoffbrand A. V., Janossy G. Enzyme and membrane markers in leukaemia: recent developments. J Clin Pathol. 1981 Mar;34(3):254–262. doi: 10.1136/jcp.34.3.254. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Hoffbrand A. V., Ma D. D., Webster A. D. Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes. Clin Haematol. 1982 Oct;11(3):719–741. [PubMed] [Google Scholar]
  43. Jani P., Verbi W., Greaves M. F., Bevan D., Bollum F. Terminal deoxynucleotidyl transferase in acute myeloid leukaemia. Leuk Res. 1983;7(1):17–29. doi: 10.1016/0145-2126(83)90054-1. [DOI] [PubMed] [Google Scholar]
  44. Janossy G., Bollum F. J., Bradstock K. F., Ashley J. Cellular phenotypes of normal and leukemic hemopoietic cells determined by analysis with selected antibody combinations. Blood. 1980 Sep;56(3):430–441. [PubMed] [Google Scholar]
  45. Janossy G., Hoffbrand A. V., Greaves M. F., Ganeshaguru K., Pain C., Bradstock K. F., Prentice H. G., Kay H. E., Lister T. A. Terminal transferase enzyme assay and immunological membrane markers in the diagnosis of leukaemia: a multiparameter analysis of 300 cases. Br J Haematol. 1980 Feb;44(2):221–234. doi: 10.1111/j.1365-2141.1980.tb01204.x. [DOI] [PubMed] [Google Scholar]
  46. Johnson S. M., North M. E., Asherson G. L., Allsop J., Watts R. W., Webster A. D. Lymphocyte purine 5'-nucleotidase edficiency in primary hypogammaglobulinaemia. Lancet. 1977 Jan 22;1(8004):168–170. doi: 10.1016/s0140-6736(77)91765-2. [DOI] [PubMed] [Google Scholar]
  47. Kass L., Munster D. Acid phosphatase in leukemic blasts: characterization by isoelectric focusing in polyacrylamide gel. Am J Hematol. 1979;6(4):381–386. doi: 10.1002/ajh.2830060410. [DOI] [PubMed] [Google Scholar]
  48. Kass L., Munster D. Nonspecific esterases in leukemic blasts. Characterization by isoelectric focusing in polyacrylamide gel. Am J Clin Pathol. 1979 Oct;72(4):611–613. doi: 10.1093/ajcp/72.4.611. [DOI] [PubMed] [Google Scholar]
  49. Kass L., Peters C. L. Esterases in acute leukemias: a cytochemical and electrophoretic study. Am J Clin Pathol. 1978 Jan;69(1):57–61. doi: 10.1093/ajcp/69.1.57. [DOI] [PubMed] [Google Scholar]
  50. Kazmers I. S., Mitchell B. S., Dadonna P. E., Wotring L. L., Townsend L. B., Kelley W. N. Inhibition of purine nucleoside phosphorylase by 8-aminoguanosine: selective toxicity for T lymphoblasts. Science. 1981 Dec 4;214(4525):1137–1139. doi: 10.1126/science.6795718. [DOI] [PubMed] [Google Scholar]
  51. Koller C. A., Mitchell B. S., Grever M. R., Mejias E., Malspeis L., Metz E. N. Treatment of acute lymphoblastic leukemia with 2'-deoxycoformycin: clinical and biochemical consequences of adenosine deaminase inhibition. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1949–1952. [PubMed] [Google Scholar]
  52. Koya M., Kanoh T., Sawada H., Uchino H., Ueda K. Adenosine deaminase and ecto-5'-nucleotidase activities in various leukemias with special reference to blast crisis: significance of ecto-5'-nucleotidase in lymphoid blast crisis of chronic myeloid leukemia. Blood. 1981 Dec;58(6):1107–1111. [PubMed] [Google Scholar]
  53. Kramers M. T., Catovsky D., Foa R., Cherchi M., Galton D. A. 5' nucleotidase activity in leukaemic lymphocytes. Biomedicine. 1976 Dec 30;25(10):363–365. [PubMed] [Google Scholar]
  54. Lafuente R., Woessner S., Sans-Sabrafen J. Isoenzymatic study of leucocytic acid phosphatase in haematologic diagnosis. Scand J Haematol. 1979 Aug;23(2):146–160. doi: 10.1111/j.1600-0609.1979.tb02686.x. [DOI] [PubMed] [Google Scholar]
  55. Li C. Y., Lam K. W., Yam L. T. Esterases in human leukocytes. J Histochem Cytochem. 1973 Jan;21(1):1–12. doi: 10.1177/21.1.1. [DOI] [PubMed] [Google Scholar]
  56. Li C. Y., Yam L. T., Lam K. W. Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions. J Histochem Cytochem. 1970 Jul;18(7):473–481. doi: 10.1177/18.7.473. [DOI] [PubMed] [Google Scholar]
  57. Li C. Y., Yam L. T., Lam K. W. Studies of acid phosphatase isoenzymes in human leukocytes demonstration of isoenzyme cell specificity. J Histochem Cytochem. 1970 Dec;18(12):901–910. doi: 10.1177/18.12.901. [DOI] [PubMed] [Google Scholar]
  58. Ma D. D., Massaia M., Sylwestrowicz T. A., Price G., Hoffbrand A. V. Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post-thymic T cells. Br J Haematol. 1983 Jul;54(3):451–457. doi: 10.1111/j.1365-2141.1983.tb02119.x. [DOI] [PubMed] [Google Scholar]
  59. Ma D. D., Sylwestrowicz T. A., Granger S., Massaia M., Franks R., Janossy G., Hoffbrand A. V. Distribution of terminal deoxynucleotidyl transferase and purine degradative and synthetic enzymes in subpopulations of human thymocytes. J Immunol. 1982 Oct;129(4):1430–1435. [PubMed] [Google Scholar]
  60. Massaia M., Ma D. D., Sylwestrowicz T. A., Tidman N., Price G., Janossy G., Hoffbrand A. V. Enzymes of purine metabolism in human peripheral lymphocyte subpopulations. Clin Exp Immunol. 1982 Oct;50(1):148–154. [PMC free article] [PubMed] [Google Scholar]
  61. McCaffrey R., Bell R., Lillquist A., Wright G., Baril E. The Bollum enzyme in leukemia and lymphoma cells: the first decade. Adv Exp Med Biol. 1982;145:221–241. doi: 10.1007/978-1-4684-8929-3_21. [DOI] [PubMed] [Google Scholar]
  62. McCaffrey R., Lillquist A., Sallan S., Cohen E., Osband M. Clinical utility of leukemia cell terminal transferase measurements. Cancer Res. 1981 Nov;41(11 Pt 2):4814–4820. [PubMed] [Google Scholar]
  63. McCaffrey R., Smoler D. F., Baltimore D. Terminal deoxynucleotidyl transferase in a case of childhood acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 1973 Feb;70(2):521–525. doi: 10.1073/pnas.70.2.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. McCulloch E. A. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982). Blood. 1983 Jul;62(1):1–13. [PubMed] [Google Scholar]
  65. McGraw T. P., Folds J. D., Bollum F. J., Stass S. A. Terminal deoxynucleotidyl transferase-positive acute myeloblastic leukemia. Am J Hematol. 1981;10(3):251–258. doi: 10.1002/ajh.2830100304. [DOI] [PubMed] [Google Scholar]
  66. Meier J., Coleman M. S., Hutton J. J. Adenosine deaminase activity in peripheral blood cells of patients with haematological malignancies. Br J Cancer. 1976 Mar;33(3):312–319. doi: 10.1038/bjc.1976.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  67. Mejer J., Nygaard P. Adenosine deaminase and purine nucleoside phosphorylase levels in acute myeloblastic leukemia cells. Relationship to diagnosis and clinical course. Leuk Res. 1979;3(4):211–216. doi: 10.1016/0145-2126(79)90044-4. [DOI] [PubMed] [Google Scholar]
  68. Mertelsmann R. The prognostic significance of terminal deoxynucleotidyl transferase (TDT) in patients with leukemias and malignant lymphomas. Adv Exp Med Biol. 1982;145:259–277. doi: 10.1007/978-1-4684-8929-3_23. [DOI] [PubMed] [Google Scholar]
  69. Mitchell B. S., Koller C. A., Heyn R. Inhibition of adenosine deaminase activity results in cytotoxicity to T lymphoblasts in vivo. Blood. 1980 Sep;56(3):556–559. [PubMed] [Google Scholar]
  70. Paietta E., Bettelheim P., Schwarzmeier J. D., Lutz D., Majdic O., Knapp W. Distinct lymphoblastic and myeloblastic populations in TdT positive acute myeloblastic leukemia: evidence by double-fluorescence staining. Leuk Res. 1983;7(2):301–307. doi: 10.1016/0145-2126(83)90021-8. [DOI] [PubMed] [Google Scholar]
  71. Poplack D. G., Sallan S. E., Rivera G., Holcenberg J., Murphy S. B., Blatt J., Lipton J. M., Venner P., Glaubiger D. L., Ungerleider R. Phase I study of 2'-deoxycoformycin in acute lymphoblastic leukemia. Cancer Res. 1981 Sep;41(9 Pt 1):3343–3346. [PubMed] [Google Scholar]
  72. Prentice H. G., Smyth J. F., Ganeshaguru K., Wonke B., Bradstock K. F., Janossy G., Goldstone A. H., Hoffbrand A. V. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia. Lancet. 1980 Jul 26;2(8187):170–172. doi: 10.1016/s0140-6736(80)90060-4. [DOI] [PubMed] [Google Scholar]
  73. Radzun H. J., Parwaresch M. R., Feller A. C. Cell-specific polymorphism of acid phosphatase in human blood cells: their functional and leukemic variants. Proc Soc Exp Biol Med. 1981 Jul;167(3):394–401. doi: 10.3181/00379727-167-41186. [DOI] [PubMed] [Google Scholar]
  74. Reaman G. H., Blatt J., Poplack D. G. Lymphoblast purine pathway enzymes in B-cell acute lymphoblastic leukemia. Blood. 1981 Aug;58(2):330–332. [PubMed] [Google Scholar]
  75. Reaman G. H., Levin N., Muchmore A., Holiman B. J., Poplack D. G. Diminished lymphoblast 5'-nucleotidase activity in acute lymphoblastic leukemia with T-cell characteristics. N Engl J Med. 1979 Jun 14;300(24):1374–1377. doi: 10.1056/NEJM197906143002406. [DOI] [PubMed] [Google Scholar]
  76. Russell N. H., Prentice H. G., Lee N., Piga A., Ganeshaguru K., Smyth J. F., Hoffbrand A. V. Studies on the biochemical sequelae of therapy in Thy-acute lymphoblastic leukaemia with the adenosine deaminase inhibitor 2' deoxycoformycin. Br J Haematol. 1981 Sep;49(1):1–9. doi: 10.1111/j.1365-2141.1981.tb07190.x. [DOI] [PubMed] [Google Scholar]
  77. Sahai Srivastava B. I., Khan S. A., Henderson E. S. High terminal deoxynucleotidyl transferase activity in acute myelogenous leukemia. Cancer Res. 1976 Oct;36(10):3847–3850. [PubMed] [Google Scholar]
  78. Smith L. J., Curtis J. E., Messner H. A., Senn J. S., Furthmayr H., McCulloch E. A. Lineage infidelity in acute leukemia. Blood. 1983 Jun;61(6):1138–1145. [PubMed] [Google Scholar]
  79. Smyth J. F., Harrap K. R. Adenosine deaminase activity in leukaemia. Br J Cancer. 1975 May;31(5):544–549. doi: 10.1038/bjc.1975.95. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Smyth J. F., Paine R. M., Jackman A. L., Harrap K. R., Chassin M. M., Adamson R. H., Johns D. G. The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin. Cancer Chemother Pharmacol. 1980;5(2):93–101. doi: 10.1007/BF00435411. [DOI] [PubMed] [Google Scholar]
  81. Smyth J. F., Poplack D. G., Holiman B. J., Leventhal B. G., Yarbro G. Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia. J Clin Invest. 1978 Sep;62(3):710–712. doi: 10.1172/JCI109179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  82. Smyth J. F., Young R. C., Young D. M. In vivo toxicity to lymphoid tissue by 2'-deoxycoformycin. Cancer Chemother Pharmacol. 1978;1(1):49–51. doi: 10.1007/BF00253146. [DOI] [PubMed] [Google Scholar]
  83. Sylwestrowicz T. A., Ma D. D., Murphy P. P., Massaia M., Prentice H. G., Hoffbrand A. V., Greaves M. F. 5'nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia. Leuk Res. 1982;6(4):475–482. doi: 10.1016/0145-2126(82)90004-2. [DOI] [PubMed] [Google Scholar]
  84. Sylwestrowicz T., Piga A., Murphy P., Ganeshaguru K., Russell N. H., Prentice H. G., Hoffbrand A. V. The effect of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells. Br J Haematol. 1982 Aug;51(4):623–630. doi: 10.1111/j.1365-2141.1982.tb02826.x. [DOI] [PubMed] [Google Scholar]
  85. Thiel E., Rodt H., Huhn D., Netzel B., Grosse-Wilde H., Ganeshaguru K., Thierfelder S. Multimarker classification of acute lymphoblastic leukemia: evidence for further T subgroups and evaluation of their clinical significance. Blood. 1980 Nov;56(5):759–772. [PubMed] [Google Scholar]
  86. Van Der Weyden M. B., Ellims P. H., Gan T. E. Enzymic markers in lymphoproliferative disorders. Am J Hematol. 1983 May;14(3):301–311. doi: 10.1002/ajh.2830140313. [DOI] [PubMed] [Google Scholar]
  87. Weber G. Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture. Cancer Res. 1983 Aug;43(8):3466–3492. [PubMed] [Google Scholar]
  88. Woessner S., Lafuente R., Capdevila J., Sans-Sabrafen J. Diagnostic value of leucocytic acid-phosphatase isoenzymes in determining cytological types of non-lymphoid acute leukaemias. Acta Haematol. 1979;61(2):85–92. doi: 10.1159/000207637. [DOI] [PubMed] [Google Scholar]
  89. Yam L. T., Li C. Y., Lam K. W. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. N Engl J Med. 1971 Feb 18;284(7):357–360. doi: 10.1056/NEJM197102182840704. [DOI] [PubMed] [Google Scholar]
  90. Yourno J., Burkart P., Lizzi F., Tartaglia A. Enzymologic classification of acute leukemias: nonspecific esterase markers distinguish myeloid and lymphoid varieties. Blood. 1982 Aug;60(2):304–308. [PubMed] [Google Scholar]
  91. van Laarhoven J. P., Spierenburg G. T., Bakkeren J. A., Schouten T. J., De Bruyn C. H., Geerts S. J., Schretlen E. D. Purine metabolism in childhood acute lymphoblastic leukemia: biochemical markers for diagnosis and chemotherapy. Leuk Res. 1983;7(3):407–420. doi: 10.1016/0145-2126(83)90105-4. [DOI] [PubMed] [Google Scholar]
  92. van de Griend R. J., van der Reijden H. J., Bolhuis R. L., Melief C. J., von dem Borne A. E., Roos D. Enzyme analysis of lymphoproliferative diseases: a useful addition to cell surface phenotyping. Blood. 1983 Sep;62(3):669–676. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES